Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 201152 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 100MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| NEVIRAPINE(UNII: 99DK7FVK1H) (NEVIRAPINE - UNII:99DK7FVK1H) | NEVIRAPINE | 400mg |
Inactive Ingredients
| Ingredient Name | Aurobindo Pharma Limited | Alvogen Inc. | Mylan Pharmaceuticals Inc. |
|---|---|---|---|
| FERRIC OXIDE YELLOW(EX438O2MRT) | |||
| HYPROMELLOSE 2208 (4000 MPA.S)(39J80LT57T) | |||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||
| HYPROMELLOSES(3NXW29V3WO) | |||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||
| SILICON DIOXIDE(ETJ7Z6XBU4) | |||
| SODIUM STEARYL FUMARATE(7CV7WJK4UI) | |||
| ZINC STEARATE(H92E6QA4FV) |
